Since there is an increase in platelet aggregation and the circulating levels of 5-HT have been reported to be elevated in diabetes [35,68], the blockade of 5-HT receptors was shown to attenuate diabetes-induced cardiovascular complications. This evidence concerns the gene HTR5A and diabetes mellitus.